Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CAnadian Normoglycemia Outcomes Evaluation Study

Trial Profile

CAnadian Normoglycemia Outcomes Evaluation Study

Phase of Trial: Phase III

Latest Information Update: 30 Jul 2018

At a glance

  • Drugs Rosiglitazone/metformin (Primary)
  • Indications Glucose intolerance; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms CANOE
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 23 May 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top